The U.S. capital markets remain an attractive source of capital for emerging companies in the life sciences sector. Approximately 21.7% of the 2017 IPOs were life sciences companies. Many of these IPOs were preceded by late stage (or mezzanine) private placements made principally to U.S. institutional investors.
During our webinar, Steve Maletzky (William Blair), along with partners David Bakst and Anna Pinedo will discuss:
CLE credit will be provided. For more information, or to register for this session, please visit the event website.
CLE is not available when viewing a recording of this program. In order to receive credit you must have attended the live webinar program.
Mayer Brown is a global legal services provider comprising associated legal practices that are separate entities, including Mayer Brown LLP (Illinois, USA), Mayer Brown International LLP (England & Wales), Mayer Brown Hong Kong LLP (a Hong Kong limited liability partnership) and Tauil & Chequer Advogados (a Brazilian law partnership) (collectively, the “Mayer Brown Practices”). The Mayer Brown Practices are established in various jurisdictions and may be a legal person or a partnership. PK Wong & Nair LLC (“PKWN”) is the constituent Singapore law practice of our licensed joint law venture in Singapore, Mayer Brown PK Wong & Nair Pte. Ltd. Mayer Brown Hong Kong LLP operates in temporary association with Johnson Stokes & Master (“JSM”). More information about the individual Mayer Brown Practices, PKWN and the association between Mayer Brown Hong Kong LLP and JSM (including how information may be shared) can be found in the Legal Notices section of our website.
“Mayer Brown” and the Mayer Brown logo are trademarks of Mayer Brown.
Attorney Advertising. Prior results do not guarantee a similar outcome.